These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 3102810)
21. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer. Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196 [TBL] [Abstract][Full Text] [Related]
22. [A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil]. Tashiro K; Kondo N; Ikemoto I Hinyokika Kiyo; 1986 Mar; 32(3):449-53. PubMed ID: 3728246 [TBL] [Abstract][Full Text] [Related]
23. Cerebral metastases secondary to ovarian cancer: still an unusual event. Bruzzone M; Campora E; Chiara S; Giudici S; Merlini L; Simoni C; Mammoliti S; Rubagotti A; Rosso R Gynecol Oncol; 1993 Apr; 49(1):37-40. PubMed ID: 8482558 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
26. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Fortin D; Gendron C; Boudrias M; Garant MP Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866 [TBL] [Abstract][Full Text] [Related]
27. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients. Ardizzoni A; Pronzato P; Conte PF; Rosso R Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624 [TBL] [Abstract][Full Text] [Related]
28. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy]. Itoshima T; Yamamoto T; Kasamatsu T; Fujino H; Yamamoto H; Morita Y; Kodama M Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355 [TBL] [Abstract][Full Text] [Related]
29. [Tumor chemotherapy of ovarian cancer patients in advanced age]. Behling H; Schirmer A; Krafft W; Brückmann D Zentralbl Gynakol; 1988; 110(2):95-101. PubMed ID: 3364065 [TBL] [Abstract][Full Text] [Related]
30. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up. Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355 [TBL] [Abstract][Full Text] [Related]
32. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952 [TBL] [Abstract][Full Text] [Related]
33. [Clinical trial of cisplatin in the treatment of ovarian carcinoma]. Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112 [TBL] [Abstract][Full Text] [Related]
34. [Preoperative chemotherapy for advanced breast cancer]. Shiba E; Nishizawa Y; Koyama H; Terasawa T Gan To Kagaku Ryoho; 1985 May; 12(5):1003-9. PubMed ID: 3922305 [TBL] [Abstract][Full Text] [Related]
35. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor]. Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732 [TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa]. Wu BZ Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851 [No Abstract] [Full Text] [Related]
38. [Polymer-drug complexes in the treatment of extensive ovarian cancer]. Novikova EG; Borisov VI; Dmitriev DG; Zel'vin BM; Karseladze AI; Shchitkov KG; Li AD Sov Med; 1991; (11):27-9. PubMed ID: 1767307 [TBL] [Abstract][Full Text] [Related]
39. [Predictive value of P53 expression in selecting first-line chemotherapy regimen for advanced epithelial ovarian carcinoma]. Zhao XD; Zhang Y; He SR; Yang L Ai Zheng; 2005 Dec; 24(12):1542-5. PubMed ID: 16351810 [TBL] [Abstract][Full Text] [Related]
40. [A case report of ovarian cancer stage Ia with micrometastasis of para-aortic lymph node]. Adachi S; Noda T; Hirano Y; Katou Y Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1459-62. PubMed ID: 1460366 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]